EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)Open Access

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy

Eleftherios P Mamounas, Hanna Bandos, Julia R White, Thomas B Julian, Atif J Khan, Simona F Shaitelman, Mylin A Torres, Frank A Vicini, Patricia A Ganz, Susan A McCloskey, Peter C Lucas, Nilendu Gupta und 16 weitere

New England Journal of Medicine · 05.06.2025 · 392 (21) · 2113-2124

DOI: 10.1056/nejmoa2414859 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 05.06.2025. Verfasst von Eleftherios P Mamounas und 27 weiteren Autor:innen. Beteiligte Einrichtung: AdventHealth Cancer Institute, Orlando, FL. Hauptthemen laut MEDLINE: Breast Neoplasms, Chemotherapy, Adjuvant, Lymphatic Irradiation, Neoadjuvant Therapy. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsChemotherapy, AdjuvantLymphatic IrradiationNeoadjuvant TherapyNeoplasm Recurrence, LocalAdultFemaleHumansMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsAxillaDisease-Free SurvivalKaplan-Meier EstimateLymph NodesLymphatic MetastasisNeoplasm StagingBiopsyFollow-Up StudiesMastectomyNeoplasm InvasivenessPathologic Complete ResponseBreastIncidence

Autor:innen und Institutionen

  • AdventHealth Cancer Institute, Orlando, FL.
  • NRG Oncology Statistical and Data Management Center, Pittsburgh.
  • University of Pittsburgh School of Public Health, Department of Biostatistics and Health Data Science, Pittsburgh.
  • University of Kansas Medical Center Comprehensive Cancer Center, Kansas City.
  • Allegheny Health Network Cancer Institute, Pittsburgh.
  • Memorial Sloan Kettering Cancer Center, New York.

ORCID-Profile: Robert W Mutter

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Clinical Center
  • Senior Scholar grant from the Susan G. Komen Foundation

Zitieren

APA

Mamounas, E. P., Bandos, H., White, J. R., Julian, T. B., Khan, A. J., Shaitelman, S. F., Torres, M. A., Vicini, F. A., Ganz, P. A., McCloskey, S. A., Lucas, P. C., Gupta, N., Li, X. A., McCormick, B., Smith, B., Tendulkar, R. D., Kavadi, V. S., Matsumoto, K., Seaward, S. A., …, & Wolmark, N. (2025). Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy. New England Journal of Medicine, 392(21), 2113-2124. https://doi.org/10.1056/nejmoa2414859

Vancouver

Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, et al. Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy. New England Journal of Medicine. 2025;392(21):2113-2124. doi:10.1056/nejmoa2414859

BibTeX
@article{Mamounas2025,
  author = {Mamounas, Eleftherios P and Bandos, Hanna and White, Julia R and Julian, Thomas B and Khan, Atif J and Shaitelman, Simona F and Torres, Mylin A and Vicini, Frank A and Ganz, Patricia A and McCloskey, Susan A and Lucas, Peter C and Gupta, Nilendu and Li, X Allen and McCormick, Beryl and Smith, Benjamin and Tendulkar, Rahul D and Kavadi, Vivek S and Matsumoto, Koji and Seaward, Samantha Andrews and Irvin, William J and Lin, Jolinta Y and Mutter, Robert W and Muanza, Thierry M and Stromberg, Jannifer and Jagsi, Reshma and Weiss, Anna C and Curran, Walter J and Wolmark, Norman},
  title = {Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {21},
  pages = {2113--2124},
  doi = {10.1056/nejmoa2414859}
}
Kostenlos starten →